Rapidly Responsive Silk Fibroin Hydrogels As an Artificial Matrix for the Programmed Tumor Cells Death
Overview
Authors
Affiliations
Timely and spatially-regulated injectable hydrogels, able to suppress growing tumors in response to conformational transitions of proteins, are of great interest in cancer research and treatment. Herein, we report rapidly responsive silk fibroin (SF) hydrogels formed by a horseradish peroxidase (HRP) crosslinking reaction at physiological conditions, and demonstrate their use as an artificial biomimetic three-dimensional (3D) matrix. The proposed SF hydrogels presented a viscoelastic nature of injectable hydrogels and spontaneous conformational changes from random coil to β-sheet conformation under physiological conditions. A human neuronal glioblastoma (U251) cell line was used for screening cell encapsulation and in vitro evaluation within the SF hydrogels. The transparent random coil SF hydrogels promoted cell viability and proliferation up to 10 days of culturing, while the crystalline SF hydrogels converted into β-sheet structure induced the formation of TUNEL-positive apoptotic cells. Therefore, this work provides a powerful tool for the investigation of the microenvironment on the programed tumor cells death, by using rapidly responsive SF hydrogels as 3D in vitro tumor models.
Leonardi F, Simonazzi B, Martini F, DAngelo P, Foresti R, Botti M Vet Sci. 2024; 11(8).
PMID: 39195822 PMC: 11360824. DOI: 10.3390/vetsci11080368.
Functional hydrogels for hepatocellular carcinoma: therapy, imaging, and in vitro model.
Xu X, Liu Y, Liu Y, Yu Y, Yang M, Lu L J Nanobiotechnology. 2024; 22(1):381.
PMID: 38951911 PMC: 11218144. DOI: 10.1186/s12951-024-02547-9.
Functionalising silk hydrogels with hetero- and homotypic nanoparticles.
Kaewchuchuen J, Matthew S, Phuagkhaopong S, Bimbo L, Seib F RSC Adv. 2024; 14(5):3525-3535.
PMID: 38259992 PMC: 10801455. DOI: 10.1039/d3ra07634b.
Madappura A, Madduri S Comput Struct Biotechnol J. 2023; 21:4868-4886.
PMID: 37860231 PMC: 10583100. DOI: 10.1016/j.csbj.2023.10.012.
Silk fibroin carriers with sustained release capacity for treating neurological diseases.
Huang X, An Y, Yuan S, Chen C, Shan H, Zhang M Front Pharmacol. 2023; 14:1117542.
PMID: 37214477 PMC: 10196044. DOI: 10.3389/fphar.2023.1117542.